4 posts tagged “eczema”

What’s your experience with Cetomacrogol cream?

Posted February 26th, 2011 by

Used to treat dry, sensitive skin as well as eczema and itching, cetomacrogol cream FNA is a mitigating and protective skin cream.  It contains cetomacrogol (an emulsifying agent), cetiol (a fast-spreading dry emollient), sorbitol (a humectant and texturizing agent), water and the preservative sorbic acid.

At PatientsLikeMe, where more than 120,000 patients are sharing their experiences with conditions, symptoms, treatments and more, over 700 patients report dry skin.  The majority rate this symptom as either “moderate” (35%) or “severe” (17%).   Primary conditions representing include everything from fibromyalgia to depression, showing that this uncomfortable symptom affects all different types of patients.

Only one member currently reports using cetomacrogol cream for dry skin.  Her treatment evaluation of cetomacrogol cream, which she rates as “moderately” effective, notes that “a little bit seemed to go a long way” and that she also used the cream as a facial moisturizer prior to makeup application.  However, she discontinued it after a year and a half of use.

If you’ve tried cetomacrogol cream or another therapeutic skin lotion, we encourage you to share your experiences to help other patients.  PatientsLikeMe’s unique data-sharing platform allows you to share detailed data about all types of treatments, interventions and lifestyle modifications that have helped you or simply had no effect.

JOIN PATIENTSLIKEME TODAY

Join PatientsLikeMe and add your experiences to our growing body of knowledge.  Then, stay to exchange advice and support, research common treatments and learn from other patients like you.


Are You Taking Asthmanex for Your Asthma?

Posted February 19th, 2011 by

Asthmanex is a brand name for the anti-inflammatory agent mometasone furoate, a corticosteroid used in various formulations (inhaler, intranasal spray or topical ointment) for the treatment of asthma and allergic rhinitis as well as inflammatory skin disorders such as eczema and psoriasis.

A prescription inhalant drug marketed by Schering-Plough, Asthmanex – which is available as a “twisthaler” – is approved for the maintenance treatment of asthma in patients four years of age and older.  A dosage of 110mcg is approved for patients age four to 11, while a dosage of 220mcg is approved for patients age 12 and older.  Asthmanex is not indicated for the rescue treatment of sudden, severe asthma symptoms.

At PatientsLikeMe, where more than 120,000 patients are sharing their experiences with conditions, symptoms, treatments and more, three patients report using Asthmanex while 27 patients report using a formulation of mometasone.  What can we learn from these patients’ experiences?  Quite a bit, actually, thanks to PatientsLikeMe’s unique data-sharing platform.  For example, the most commonly reported mometasone duration amongst current users is two years or more, while the top reasons for discontinuing the mediation include doctors’ advice, expense and “it did not seem to work.”

Wondering about side effects?  Only one patient ranked the side effects as “mild,” while zero patients reported having “moderate” or “severe” side effects.  Check out the three treatment evaluations of Asthmanex and eight treatment evaluations of mometasone submitted by our patients to gain even more insight.

JOIN PATIENTSLIKEME TODAY

Have you taken Asthmanex – or another form of mometasone?  Join PatientsLikeMe and add your experiences to our growing body of knowledge.  Then, stay to exchange advice and support, research common treatments and learn from other patients like you.

Join PatientsLikeMe